Ace strengthens position in field of pharmaceutical compounding by taking over Pharmalot

Synergy

The take over of Pharmalot enables Ace to strengthen her position. "We see diverse risks and challenges coming at us within the field of pharmaceutical compounding. The synergistic opportunities we see by merging Ace with Pharmalot will lead to an even broader portfolio of quality compounded pharmaceuticals for both pharmacy and patient. This allows the fulfillment of a complete service approach and one-stop-shop objective by Ace", says Jan Verwaal, CEO of Ace.

Basic Pharma and Mosadex, current shareholders in Pharmalot, are convinced that concentrating pharmaceutical compounding at Ace is the best guarantee for continuity and optimalisation of the development opportunities in this field.

Strategic collaboration with Basic Pharma

The sale of Pharmalot to Ace gives Basic Pharma the opportunity to focus on the growth of her core activities in the development and production of medicines and providing services to the pharmaceutical industry. "Basic Pharma and Ace are committed to work closely together when it comes to quality control, production and product development of medicines", says Bob Kool, CEO of Basic Pharma.

Ace Compounding

Ace Compounding is a joint venture of Ace Holding, parent company of Ace Pharmaceuticals, and Mosadex Group. Ace is located in Zeewolde (the Netherlands) and has been providing custom pharmaceutical solutions for specific patient needs for over 30 years. This is done by providing licensed medicines, Clinical Trial Medication, supply in named patient programs and, since 2020, via Ace Compounding also compounded pharmaceuticals for Dutch pharmacies.

Basic Pharma

Basic Pharma is an independent pharmaceutical group of companies that are primarily engaged in the development, licensing, production and commercialisation of pharmaceutical and biopharmaceuticals products as well as providing services to the pharmaceutical industry like quality control, regulatory services, pharmacovigilance services, quality services and support and project management in product development.

Mosadex Group

As a full range supplier in the pharmaceutical industry, Mosadex Group supports throught its 12 subsidiaries over 800 independent public pharmacies with an optimal business operation, distribution of care supplies and medicines, (self) care and digitalisation. Mosadex Group is characterised by its cooperative structure and with her members she is close to the market and knows what is going on.